Distinguishing Hypervascular Pseudolesions of the Liver from Hypervascular Hepatocellular Carcinomas with Gadoxetic Acid–enhanced MR Imaging

Abstract

Gadoxetic acid-enhanced hepatocyte-phase MR imaging and DW imaging could be used to distinguish hypervascular pseudolesions from hypervascular HCCs; a hepatocyte-phase SI ratio below 0.84 and visibility on DW images were findings specific for HCCs rather than pseudolesions.